Attovia Therapeutics (ATTO) awards 140,000 stock options to Chief Medical Officer
Rhea-AI Filing Summary
Attovia Therapeutics, Inc. reported that Chief Medical Officer Chen Hubert received a grant of stock options covering 140,000 shares of common stock on August 4, 2026. The options have an exercise price of $17.00 per share and expire on August 3, 2036. Following this grant, Hubert holds 140,000 options directly. According to the vesting terms, 25% of the options vest on August 4, 2027, with the remaining options vesting in equal monthly installments over the subsequent 36 months, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Chen Hubert
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 140,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 140,000 shares (Direct)
Footnotes (1)
- F1. 25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates.
Key Figures
Options granted: 140,000 options
Exercise price: $17.00 per share
Expiration date: August 3, 2036
+3 more
6 metrics
Options granted
140,000 options
Stock option grant to Chief Medical Officer on August 4, 2026
Exercise price
$17.00 per share
Exercise price for 140,000 stock options
Expiration date
August 3, 2036
Option term end date for the 140,000 options
Initial vesting
25% on August 4, 2027
First vesting tranche of the option grant
Remaining vesting period
36 months
Monthly vesting of remaining options after initial 25% vests
Options held after grant
140,000 options
Total options directly held by Chen Hubert after this transaction
Key Terms
Stock Option (Right to Buy), exercise price, vesting, monthly installments
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 17.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the options shall vest on August 4, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
monthly installments financial
"remaining options shall vest in equal monthly installments"
Monthly installments are regular, fixed payments made each month to gradually pay off a larger amount, such as a loan or purchase. Think of it like paying for a big item in small, manageable parts instead of all at once. For investors, understanding installment payments helps gauge how debts are structured and how they might affect financial stability or cash flow over time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Attovia Therapeutics (ATTO) disclose about Chen Hubert’s new stock options?
Attovia Therapeutics disclosed that Chief Medical Officer Chen Hubert received a grant of 140,000 stock options on August 4, 2026, with an exercise price of $17.00 per share and expiration on August 3, 2036.
What is the vesting schedule of Chen Hubert’s 140,000 options at ATTO?
The 140,000 options granted to Chen Hubert vest 25% on August 4, 2027. The remaining 75% vest in equal monthly installments over the next 36 months, contingent on his continued service with Attovia Therapeutics.
What is the exercise price of the stock options granted to ATTO’s Chief Medical Officer?
The options granted to Attovia’s Chief Medical Officer carry an exercise price of $17.00 per share. They relate to 140,000 shares of common stock and are structured as a standard stock option (right to buy) award.
How many options does Chen Hubert hold after this Form 4 transaction for ATTO?
After this reported transaction, Chief Medical Officer Chen Hubert holds 140,000 stock options directly. These options were acquired as a grant and are subject to the stated vesting schedule and expiration on August 3, 2036.
When do the newly granted ATTO options to Chen Hubert expire?
The stock options granted to Chen Hubert expire on August 3, 2036. They were granted on August 4, 2026, have an exercise price of $17.00 per share, and vest over approximately four years based on continued service.